Japan Gene Therapy Market Research Report 2018

March 2018 | 96 pages | ID: J8DBFA8EC78EN
QYResearch

Abstracts

The global Gene Therapy market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Japan plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.

This report studies the Gene Therapy development status and future trend in Japan, focuses on top players in Japan, also splits Gene Therapy by type and by Application, to fully and deeply research and reveal the market general situation and future forecast.

The major players in Japan market include

• Sangamo
• Spark Therapeutics
• Dimension Therapeutics
• Avalanche Bio
• Celladon
• Vical
• Advantagene

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Ex vivo
• In vivo

On the basis of the end users/Application, this report covers

• Cancer Diseases
• Monogenic Diseases
• Infectious Diseases
• Cardiovascular Diseases
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Japan Gene Therapy Market Research Report 2018

1 GENE THERAPY OVERVIEW

1.1 Product Overview and Scope of Gene Therapy
1.2 Classification of Gene Therapy by Product Category
  1.2.1 Japan Gene Therapy Sales (K Units) Comparison by Type (2013-2025)
  1.2.2 Japan Gene Therapy Sales (K Units) Market Share by Type in 2017
  1.2.3 Ex vivo
  1.2.4 In vivo
1.3 Japan Gene Therapy Market by Application/End Users
  1.3.1 Japan Gene Therapy Sales (K Units) and Market Share Comparison by Application (2013-2025)
  1.3.2 Cancer Diseases
  1.3.3 Monogenic Diseases
  1.3.4 Infectious Diseases
  1.3.5 Cardiovascular Diseases
  1.3.6 Others
1.4 Japan Revenue and Sales of Gene Therapy (2013-2025)
  1.4.1 Japan Gene Therapy Sales (K Units) and Growth Rate (%)(2013-2025)
  1.4.2 Japan Gene Therapy Revenue (Million USD) and Growth Rate (%)(2013-2025)

2 JAPAN GENE THERAPY MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 Japan Gene Therapy Sales (K Units) and Market Share (%) of Key Players/Manufacturers (2013-2018)
2.2 Japan Gene Therapy Revenue and Share by Players/Manufacturers (2013-2018)
2.3 Japan Gene Therapy Average Price (USD/Unit) by Players/Manufacturers (2013-2018)
2.4 Japan Gene Therapy Market Competitive Situation and Trends
  2.4.1 Japan Gene Therapy Market Concentration Rate
  2.4.2 Japan Gene Therapy Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in Japan Market
2.5 Japan Players/Manufacturers Gene Therapy Manufacturing Base Distribution, Sales Area, Product Type

3 JAPAN GENE THERAPY SALES AND REVENUE (VALUE) BY TYPE (2013-2018)

3.1 Japan Gene Therapy Sales (K Units) and Market Share by Type/ Product Category (2013-2018)
3.2 Japan Gene Therapy Revenue (Million USD) and Market Share by Type (2013-2018)
3.3 Japan Gene Therapy Price (USD/Unit) by Type (2013-2018)
3.4 Japan Gene Therapy Sales Growth Rate (%) by Type (2013-2018)

4 JAPAN GENE THERAPY SALES BY APPLICATION (2013-2018)

4.1 Japan Gene Therapy Sales (K Units) and Market Share by Application (2013-2018)
4.2 Japan Gene Therapy Sales Growth Rate (%) by Application (2013-2018)
4.3 Market Drivers and Opportunities

5 JAPAN GENE THERAPY PLAYERS/SUPPLIERS PROFILES AND SALES DATA

5.1 Sangamo
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Gene Therapy Product Category, Application and Specification
    5.1.2.1 Product A
    5.1.2.2 Product B
  5.1.3 Sangamo Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  5.1.4 Main Business/Business Overview
5.2 Spark Therapeutics
  5.2.1 Company Basic Information, Manufacturing Base and Competitors
  5.2.2 Gene Therapy Product Category, Application and Specification
    5.2.2.1 Product A
    5.2.2.2 Product B
  5.2.3 Spark Therapeutics Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  5.2.4 Main Business/Business Overview
5.3 Dimension Therapeutics
  5.3.1 Company Basic Information, Manufacturing Base and Competitors
  5.3.2 Gene Therapy Product Category, Application and Specification
    5.3.2.1 Product A
    5.3.2.2 Product B
  5.3.3 Dimension Therapeutics Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  5.3.4 Main Business/Business Overview
5.4 Avalanche Bio
  5.4.1 Company Basic Information, Manufacturing Base and Competitors
  5.4.2 Gene Therapy Product Category, Application and Specification
    5.4.2.1 Product A
    5.4.2.2 Product B
  5.4.3 Avalanche Bio Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  5.4.4 Main Business/Business Overview
5.5 Celladon
  5.5.1 Company Basic Information, Manufacturing Base and Competitors
  5.5.2 Gene Therapy Product Category, Application and Specification
    5.5.2.1 Product A
    5.5.2.2 Product B
  5.5.3 Celladon Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  5.5.4 Main Business/Business Overview
5.6 Vical
  5.6.1 Company Basic Information, Manufacturing Base and Competitors
  5.6.2 Gene Therapy Product Category, Application and Specification
    5.6.2.1 Product A
    5.6.2.2 Product B
  5.6.3 Vical Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  5.6.4 Main Business/Business Overview
5.7 Advantagene
  5.7.1 Company Basic Information, Manufacturing Base and Competitors
  5.7.2 Gene Therapy Product Category, Application and Specification
    5.7.2.1 Product A
    5.7.2.2 Product B
  5.7.3 Advantagene Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  5.7.4 Main Business/Business Overview

6 GENE THERAPY MANUFACTURING COST ANALYSIS

6.1 Gene Therapy Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Gene Therapy

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Gene Therapy Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Gene Therapy Major Manufacturers in 2017
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 JAPAN GENE THERAPY MARKET SIZE (SALES AND REVENUE) FORECAST (2018-2025)

10.1 Japan Gene Therapy Sales (K Units), Revenue (Million USD) Forecast (2018-2025)
10.2 Japan Gene Therapy Sales (K Units) Forecast by Type (2018-2025)
10.3 Japan Gene Therapy Sales (K Units) Forecast by Application (2018-2025)

11 RESEARCH FINDINGS AND CONCLUSION



The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Japan Market Size (Million USD) Status and Outlook (2013-2025)
Table Gene Therapy Sales (K Units) and Revenue (Million USD) Market Split by Product Type
Table Gene Therapy Sales (K Units) by Application (2017-2025)
Figure Product Picture of Gene Therapy
Table Japan Gene Therapy Sales (K Units) and Growth Rate (%) Comparison by Type (Product Category) (2013-2025)
Figure Japan Gene Therapy Sales Volume Market Share by Type in 2017
Figure Ex vivo Product Picture
Figure In vivo Product Picture
Figure Japan Gene Therapy Sales (K Units) Comparison by Application (2013-2025)
Figure Japan Sales Market Share (%) of Gene Therapy by Application in 2017
Figure Cancer Diseases Examples
Figure Monogenic Diseases Examples
Figure Infectious Diseases Examples
Figure Cardiovascular Diseases Examples
Figure Others Examples
Figure Japan Gene Therapy Sales (K Units) and Growth Rate (%)(2013-2025)
Figure Japan Gene Therapy Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table Japan Gene Therapy Sales of Key Players/Manufacturers (2013-2018)
Table Japan Gene Therapy Sales Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 Japan Gene Therapy Sales Share (%) by Players/Manufacturers
Figure 2017 Japan Gene Therapy Sales Share (%) by Players/Manufacturers
Table Japan Gene Therapy Revenue by Players/Manufacturers (2013-2018)
Table Japan Gene Therapy Revenue Market Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 Japan Gene Therapy Revenue Share (%) by Players/Manufacturers
Figure 2017 Japan Gene Therapy Revenue Share (%) by Players/Manufacturers
Table Japan Market Gene Therapy Average Price (USD/Unit) of Key Players/Manufacturers (2013-2018)
Figure Japan Market Gene Therapy Average Price (USD/Unit) of Key Players/Manufacturers in 2017
Figure Japan Gene Therapy Market Share of Top 3 Players/Manufacturers
Figure Japan Gene Therapy Market Share of Top 5 Players/Manufacturers
Table Japan Players/Manufacturers Gene Therapy Manufacturing Base Distribution and Sales Area
Table Japan Players/Manufacturers Gene Therapy Product Category
Table Japan Gene Therapy Sales (K Units) by Type (2013-2018)
Table Japan Gene Therapy Sales Share (%) by Type (2013-2018)
Figure Japan Gene Therapy Sales Share (%) by Type (2013-2018)
Figure Japan Gene Therapy Sales Market Share (%) by Type in 2017
Table Japan Gene Therapy Revenue (Million USD) and Market Share by Type (2013-2018)
Table Japan Gene Therapy Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share of Gene Therapy by Type (2013-2018)
Figure Revenue Market Share of Gene Therapy by Type in 2017
Table Japan Gene Therapy Price (USD/Unit) by Type (2013-2018)
Figure Japan Gene Therapy Sales Growth Rate (%) by Type (2013-2018)
Table Japan Gene Therapy Sales (K Units) by Application (2013-2018)
Table Japan Gene Therapy Sales Market Share (%) by Application (2013-2018)
Figure Japan Gene Therapy Sales Market Share (%) by Application (2013-2018)
Figure Japan Gene Therapy Sales Market Share (%) by Application in 2017
Table Japan Gene Therapy Sales Growth Rate (%) by Application (2013-2018)
Figure Japan Gene Therapy Sales Growth Rate (%) by Application (2013-2018)
Table Sangamo Gene Therapy Basic Information List
Table Sangamo Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Sangamo Gene Therapy Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Sangamo Gene Therapy Sales Market Share (%) in Japan (2013-2018)
Figure Sangamo Gene Therapy Revenue Market Share (%) in Japan (2013-2018)
Table Spark Therapeutics Gene Therapy Basic Information List
Table Spark Therapeutics Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Spark Therapeutics Gene Therapy Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Spark Therapeutics Gene Therapy Sales Market Share (%) in Japan (2013-2018)
Figure Spark Therapeutics Gene Therapy Revenue Market Share (%) in Japan (2013-2018)
Table Dimension Therapeutics Gene Therapy Basic Information List
Table Dimension Therapeutics Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Dimension Therapeutics Gene Therapy Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Dimension Therapeutics Gene Therapy Sales Market Share (%) in Japan (2013-2018)
Figure Dimension Therapeutics Gene Therapy Revenue Market Share (%) in Japan (2013-2018)
Table Avalanche Bio Gene Therapy Basic Information List
Table Avalanche Bio Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Avalanche Bio Gene Therapy Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Avalanche Bio Gene Therapy Sales Market Share (%) in Japan (2013-2018)
Figure Avalanche Bio Gene Therapy Revenue Market Share (%) in Japan (2013-2018)
Table Celladon Gene Therapy Basic Information List
Table Celladon Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Celladon Gene Therapy Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Celladon Gene Therapy Sales Market Share (%) in Japan (2013-2018)
Figure Celladon Gene Therapy Revenue Market Share (%) in Japan (2013-2018)
Table Vical Gene Therapy Basic Information List
Table Vical Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Vical Gene Therapy Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Vical Gene Therapy Sales Market Share (%) in Japan (2013-2018)
Figure Vical Gene Therapy Revenue Market Share (%) in Japan (2013-2018)
Table Advantagene Gene Therapy Basic Information List
Table Advantagene Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Advantagene Gene Therapy Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Advantagene Gene Therapy Sales Market Share (%) in Japan (2013-2018)
Figure Advantagene Gene Therapy Revenue Market Share (%) in Japan (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gene Therapy
Figure Manufacturing Process Analysis of Gene Therapy
Figure Gene Therapy Industrial Chain Analysis
Table Raw Materials Sources of Gene Therapy Major Players/Manufacturers in 2017
Table Major Buyers of Gene Therapy
Table Distributors/Traders List
Figure Japan Gene Therapy Sales (K Units) and Growth Rate (%) Forecast (2018-2025)
Figure Japan Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Gene Therapy Price (USD/Unit) Trend Forecast (2018-2025)
Table Japan Gene Therapy Sales (K Units) Forecast by Type (2018-2025)
Figure Japan Gene Therapy Sales (K Units) Forecast by Type (2018-2025)
Figure Japan Gene Therapy Sales Volume Market Share Forecast by Type in 2025
Table Japan Gene Therapy Sales (K Units) Forecast by Application (2018-2025)
Figure Japan Gene Therapy Sales Volume Market Share Forecast by Application (2018-2025)
Figure Japan Gene Therapy Sales Volume Market Share Forecast by Application in 2025